I C van Eijk

Erythrocyte sedimentation rate, C‐reactive protein level, and serum amyloid A protein for patient selection and monitoring of anti–tumor necrosis factor treatment in ankylosing spondylitis

Mirjam K. de Vries, I C van Eijk, Irene van der Horst‐Bruinsma et al. · Arthritis Care & Research · 2009 · 132 citations

Patient Selection, Immunology, Pathology +22

Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor α blockade

I C van Eijk, M.J. Peters, Erik H. Serné et al. · Annals of the Rheumatic Diseases · 2008 · 119 citations · Full text

Signs of Accelerated Preclinical Atherosclerosis in Patients with Ankylosing Spondylitis

Mike J. Peters, I C van Eijk, Yvo M. Smulders et al. · The Journal of Rheumatology · 2009 · 112 citations · Full text

Improvement of lipid profile is accompanied by atheroprotective alterations in high‐density lipoprotein composition upon tumor necrosis factor blockade: A prospective cohort study in ankylosing spondylitis

I C van Eijk, Mirjam K. de Vries, J.H.M. Levels et al. · Arthritis & Rheumatism · 2009 · 110 citations

Diagnosing ANCA-associated vasculitis in ANCA positive patients

Eline Houben, Willem A. Bax, Bastiaan van Dam et al. · Medicine · 2016 · 71 citations · Full text